| Literature DB >> 33154146 |
Luke David Hunter1, Mark Monaghan2, Guy Lloyd3,4,5,6, Carl Lombard7, Alfonso Jan Kemp Pecoraro8, Anton Frans Doubell8, Philipus George Herbst8.
Abstract
OBJECTIVE: The World Heart Federation (WHF) criteria incorporate a Doppler-based system to differentiate between 'physiological' and 'pathological' mitral regurgitation (MR)-a sole criterion sufficient for the diagnosis of WHF 'borderline' rheumatic heart disease (RHD). We have identified that interscallop separations (ISS) of the posterior mitral valve (MV) leaflet, can give rise to pathological MR in an otherwise-normal MV. We aimed to establish and compare the prevalence of ISS-related MR among South African children at high and low risk for RHD.Entities:
Keywords: echocardiography; heart valve diseases; mitral regurgitation
Mesh:
Year: 2020 PMID: 33154146 PMCID: PMC7646362 DOI: 10.1136/openhrt-2020-001452
Source DB: PubMed Journal: Open Heart ISSN: 2053-3624
Figure 1Echocardiographic representation of a mitral valve in the parasternal short axis view (PSSAX). The posterior leaflet has been sectioned at the tips demonstrating three examples of interscallop separation of variable location, size and shape.
Demographic parameters of the high-risk and low-risk cohorts
| Low-risk cohort | High-risk cohort | |
| N (%) | N (%) | |
| Gender (% female) | 189 (52.6) | 272* (68) |
| Age (mean) | 15.5 | 15.5 |
| Population group | ||
| Black South African | 17 (4.7) | 400* (100) |
| White South African | 319* (88.8) | 0 (0) |
| Mixed South African | 23* (6.4) | 0 (0) |
*P<0.001.
Frequency and location of interscallop separation(s) (ISS) detected by handheld echocardiography
| Low-risk cohort | High-risk cohort | |
| n (%) | n(%) | |
| No/indeterminate ISS* | 90 (25) | 121 (30.2) |
| Isolated ISS† | ||
| P1 | 1 (0.4) | 8‡ (2.9) |
| P2 | 40 (14.8) | 37 (13.3) |
| P3 | 42 (15.6) | 16‡ (5.8) |
| P1/P2 | 6 (2.2) | 13 (4.7) |
| P2/P3 | 136 (50.6) | 142 (51) |
| >1 ISS† | ||
| Double ISS | 37 (13.8) | 55 (19.8) |
| Treble ISS | 7 (2.6) | 6 (2.2) |
| Quadruple ISS | 0 (0) | 1 (0.3) |
*Calculated as a percentage of the entire cohort.
†Calculated as a percentage of cases with identifiable ISS of the posterior mitral valve leaflet.
‡P<0.05.
Amalgamated study data cross referencing mitral regurgitation (MR) prevalence, interscallop separation (ISS) and World Heart Federation (WHF) screen-positive disease
| Low-risk cohort | High-risk cohort | Total (n/%)* | |
| All ISS cases(n/%)† | 269 (74.9) | 278 (69.5) | 547 (72) |
| ISS-related MR (n/%)† | 55 (15.3) | 49 (12.3) | 104 (13.7) |
| ISS-related ‘pathological’ MR (n/%)† | 11(3) | 11 (2.8) | 22 (2.9) |
| All cases with any MR (n/%)† | 103 (28.7) | 100(25) | 203 (26.7) |
| MR screening ≥1.5 cm (n/%)† | 19 (5.3) | 23 (5.8) | 42 (5.5) |
| WHF pathological MR (n/%)† | 14 (3.9) | 13 (0.25) | 27 (3.6) |
| WHF ‘screen-positive’ cases (n/%)† | 14 (3.9) | 13 (3.3) | 27 (3.6) |
| WHF ‘borderline RHD’ (n/%)† | 14 (3.9) | 11 (2.8) | 25 (3.3) |
| WHF ‘definite RHD’ (n/%)† | 0 (0) | 2 (0.5) | 2 (0.3) |
*Calculated as a percentage of the total enrolled participants.
†Calculated as a percentage of the respective cohort.
MR, mitral regurgitation; RHD, rheumatic heart disease.
Degree and associated mechanism of mitral regurgitation (MR) among screened low-risk and high-risk children
| MR grade | Low-risk cohort (n=359) | High-risk cohort (n=400) | ||||||||
| ISS | MVP/MVP-spectrum | Pseudoprolapse | Indeterminate | Total* | ISS | MVP/MVP-spectrum | Pseudoprolapse | Indeterminate | Total* | |
| MR (All) | 55 (53.4) | 1 (1) | 0 (0) | 47 (45.6) | 103 (28.7) | 49 (49) | 5 (5) | 2 (2) | 44 (44) | 100 (25) |
| MR (1 cm<2 cm) | 34 (50) | 1 (1.5) | 0 (0) | 33 (48.5) | 68 (18.9) | 28 (49.1) | 3 (5.3) | 0 (0) | 26 (45.6) | 57 (14.3) |
| MR (≥2 cm) | 15 (65.2) | 0 (0) | 0 (0) | 8 (34.8) | 23 (6.4) | 12 (60) | 2 (10) | 2 (10) | 4 (20) | 20 (5) |
| MR (WHF path) | 11 (78.5) | 0 (0) | 0 (0) | 3 (21.4) | 14 (3.9) | 11 (84.6) | 0 (0) | 2 (15.4) | 0 (0) | 13 (3.3) |
*Calculated as a percentage of the entire cohort.
ISS, inter-scallop separation; MVP, mitral valve prolapse; WHF path, World Heart Federation ‘pathological MR’ on comprehensive study.